Article Information
History
- November 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Isabel Bünger1,2,†,
- Konstantin L. Makridis3,4,5,6,†,7,
- Jakob Kreye1,2,3,4,5,7,
- Marc Nikolaus3,4,5,7,
- Eva Sedlin3,4,
- Tim Ullrich3,4,
- Helle Foverskov Rasmussen1,2,
- Dragomir Milovanovic2,
- Christian Hoffmann2,
- Johannes Tromm2,
- Markus Höltje8,
- Harald Prüss1,2,# and
- Angela M. Kaindl3,4,5,6,#,*
- 1Charité – Universita□tsmedizin Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany
- 2German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
- 3Charité – Universita□tsmedizin Berlin, Department of Pediatric Neurology, Berlin, Germany
- 4Charité – Universita□tsmedizin Berlin, Center for Chronically Sick Children, Berlin, Germany
- 5Charité – Universita□tsmedizin Berlin, German Epilepsy Center for Children and Adolescents, Berlin, Germany
- 6Charité – Universita□tsmedizin Berlin, Institute of Cell- and Neurobiology, Berlin, Germany
- 7Berlin Institute of Health (BIH), 10178, Berlin, Germany
- 8Charité - Universita□tsmedizin Berlin, Institute of Integrative Neuroanatomy, Berlin, Germany
- ↵*Corresponding author:
Prof. Dr. med Angela M. Kaindl, Pediatric Neurology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. Tel: +49 30 450 566112. E-Mail: angela.kaindl{at}charite.de
Posted November 18, 2022.
Maternal synapsin 1 autoantibodies are associated with neurodevelopmental delay
